CT-20

N/A

Report date: 2025/06/06 20:01:13
NME

Base Information

Drug NameCT-20
Drug Alias NameCT-20CT-G20
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCardiomyopathy, Hypertrophic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandSouth Korea
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCelltrion Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelltrion Inc
Active IndicationsN/A
Inactive IndicationsCardiomyopathy, Hypertrophic

Other Information

ATC CodeN/A
Related LinksN/A